Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280600-14-000029
Filing Date
2014-11-07
Accepted
2014-11-07 09:28:08
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlrn-2014930x10q.htm 10-Q 903826
2 EXHIBIT 31.1 xlrn-2014930xexhibit311.htm EX-31.1 12491
3 EXHIBIT 31.2 xlrn-2014930xexhibit312.htm EX-31.2 12502
4 EXHIBIT 32.1 xlrn-2014930xexhibit321.htm EX-32.1 9950
  Complete submission text file 0001280600-14-000029.txt   6577935

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xlrn-20140930.xml EX-101.INS 1022096
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20140930.xsd EX-101.SCH 52818
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20140930_cal.xml EX-101.CAL 55300
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20140930_def.xml EX-101.DEF 243819
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20140930_lab.xml EX-101.LAB 622717
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20140930_pre.xml EX-101.PRE 353562
Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36065 | Film No.: 141202929
SIC: 2836 Biological Products, (No Diagnostic Substances)